- STAT+: Will Makary’s FDA voucher program survive?RevMed's cancer drug feels out of reach for some, SCOTUS preserves key generic drug pathway, and more biotech newsSTAT · 1mo ago↗ source
- STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.STAT · 1mo ago↗ source
- Texas AG investigating energy drinksThe limitations of private health insurance, the quiet collapse of America's research ethics watchdog and other Morning Rounds newsSTAT · 1mo ago↗ source